All Stories

  1. Metavac-RSV mucosal bivalent vaccine candidate protects cotton rats against pneumoviruses and is produced using serum-free cell culture in bioreactor
  2. Enterovirus D68 infection in cotton rats results in systemic inflammation with detectable viremia associated with extracellular vesicle and neurologic disease
  3. An adenoviral vector encoding an inflammation-inducible antagonist, HMGB1 Box A, as a novel therapeutic approach to inflammatory diseases
  4. Preclinical development of the TLR4 antagonist FP12 as a drug lead targeting the HMGB1/MD-2/TLR4 axis in lethal influenza infection
  5. Optimising Bioprinting Nozzles through Computational Modelling and Design of Experiments
  6. Systematic computer-aided disulfide design as a general strategy to stabilize prefusion class I fusion proteins
  7. Alzheimer’s disease and multiple sclerosis: a possible connection through the viral demyelinating neurodegenerative trigger (vDENT)
  8. Novel neuroendocrine role of γ-aminobutyric acid and gastrin-releasing peptide in the host response to influenza infection
  9. Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
  10. Human Metapneumovirus (hMPV) Infection and MPV467 Treatment in Immunocompromised Cotton Rats Sigmodon hispidus
  11. SARS-CoV-2 infection augments species- and age-specific predispositions in cotton rats
  12. Correlative outcomes of maternal immunization against RSV in cotton rats
  13. Evidence for Interplay Between the Renin–Angiotensin System and Toll-Like Receptor 4 Signaling Pathways in the Induction of Virus-Induced Acute Lung Injury
  14. Species-specific transcriptomic changes upon respiratory syncytial virus infection in cotton rats
  15. Protection against influenza-induced Acute Lung Injury (ALI) by enhanced induction of M2a macrophages: possible role of PPARγ/RXR ligands in IL-4-induced M2a macrophage differentiation
  16. Human Adenovirus Type 4 Comprises Two Major Phylogroups with Distinct Replicative Fitness and Virulence Phenotypes
  17. Evolution of protection after maternal immunization for respiratory syncytial virus in cotton rats
  18. Targeting TLR4 Signaling to Blunt Viral-Mediated Acute Lung Injury
  19. Microbial community structure and composition is associated with host species and sex in Sigmodon cotton rats
  20. HUMAN ADENOVIRUS TYPE 4 COMPRISES TWO MAJOR PHYLOGROUPS WITH DISTINCT REPLICATIVE FITNESS AND VIRULENCE PHENOTYPES
  21. A mouse model of human TLR4 D299G/T399I SNPs reveals mechanisms of altered LPS and pathogen responses
  22. Effect of aging on immunogenicity and efficacy of inactivated influenza vaccines in cotton rats Sigmodon hispidus
  23. Early or Late Bacterial Lung Infection Increases Mortality After Traumatic Brain Injury in Male Mice and Chronically Impairs Monocyte Innate Immune Function
  24. Comparisons of Antibody Populations in Different Pre-Fusion F VLP-Immunized Cotton Rat Dams and Their Offspring
  25. Select targeting of intracellular Toll-interleukin-1 receptor resistance domains for protection against influenza-induced disease
  26. Classical Drug Digitoxin Inhibits Influenza Cytokine Storm, With Implications for Covid-19 Therapy
  27. Herpes Simplex Virus 1 Induces Brain Inflammation and Multifocal Demyelination in the Cotton Rat Sigmodon hispidus
  28. Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus
  29. Influenza “Trains” the Host for Enhanced Susceptibility to Secondary Bacterial Infection
  30. Novel role of gastrin releasing peptide-mediated signaling in the host response to influenza infection
  31. Cotton rat lung transcriptome reveals host immune response to Respiratory Syncytial Virus infection
  32. Improving ability of RSV microneutralization assay to detect G-specific and cross-reactive neutralizing antibodies through immortalized cell line selection
  33. A multifaceted approach to RSV vaccination
  34. Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
  35. Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections
  36. Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus
  37. Enhancing the Thermostability and Immunogenicity of a Respiratory Syncytial Virus (RSV) Live-Attenuated Vaccine by Incorporating Unique RSV Line19F Protein Residues
  38. Immunization with Live Human Rhinovirus (HRV) 16 Induces Protection in Cotton Rats against HRV14 Infection
  39. Preclinical assessment of safety of maternal vaccination against respiratory syncytial virus (RSV) in cotton rats
  40. TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection
  41. A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation
  42. Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus)
  43. Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton rats
  44. Epigenetic Mechanisms Governing Innate Inflammatory Responses
  45. A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats
  46. Enhanced allergic responsiveness after early childhood infection with respiratory viruses: Are long-lived alternatively activated macrophages the missing link?
  47. Novel strategies for targeting innate immune responses to influenza
  48. Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein
  49. Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy
  50. Treatment with novel RSV Ig RI-002 controls viral replication and reduces pulmonary damage in immunocompromised Sigmodon hispidus
  51. Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model
  52. Novel drugs targeting Toll-like receptors for antiviral therapy
  53. Agents that increase AAM differentiation blunt RSV-mediated lung pathology
  54. A recombinant anchorless respiratory syncytial virus (RSV) fusion (F) protein/monophosphoryl lipid A (MPL) vaccine protects against RSV-induced replication and lung pathology
  55. Modeling Human Respiratory Viral Infections in the Cotton Rat (Sigmodon hispidus)
  56. Prophylactic antibody treatment and intramuscular immunization reduce infectious human rhinovirus 16 load in the lower respiratory tract of challenged cotton rats
  57. Role of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathology
  58. The TLR4 antagonist Eritoran protects mice from lethal influenza infection
  59. The Cotton Rat Sigmodon Hispidus Model of Respiratory Syncytial Virus Infection
  60. Chronic Helminth Infection Does Not Exacerbate Mycobacterium tuberculosis Infection
  61. Receptor Characterization and Susceptibility of Cotton Rats to Avian and 2009 Pandemic Influenza Virus Strains
  62. Respiratory Syncytial Virus Fusion Protein-Induced Toll-Like Receptor 4 (TLR4) Signaling Is Inhibited by the TLR4 Antagonists Rhodobacter sphaeroides Lipopolysaccharide and Eritoran (E5564) and Requires Direct Interaction with MD-2
  63. The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-β-mediated antiviral activity in vitro and in vivo
  64. New insights for development of a safe and protective RSV vaccine
  65. Activation of Interferon Response Through Toll-Like Receptor 3 Impacts Viral Pathogenesis and Pulmonary Toll-Like Receptor Expression During Respiratory Syncytial Virus and Influenza Infections in the Cotton RatSigmodon hispidusModel
  66. Control of RSV-induced lung injury by alternatively activated macrophages is IL-4Rα-, TLR4- and IFN-β-dependent
  67. Methods for Monitoring Dynamics of Pulmonary RSV Replication by Viral Culture and by Real‐Time Reverse Transcription–PCR In Vivo: Detection of Abortive Viral Replication
  68. Inactivation of respiratory syncytial virus by zinc finger reactive compounds
  69. The cotton rat model of respiratory viral infections
  70. Characterization of late tuberculosis infection in Sigmodon hispidus
  71. Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection
  72. Induction of type I interferons and interferon-inducible Mx genes during respiratory syncytial virus infection and reinfection in cotton rats
  73. Co-infection of the cotton rat (Sigmodon hispidus) with Staphylococcus aureus and influenza A virus results in synergistic disease
  74. The Antiviral Potential of Interferon-Induced Cotton Rat Mx Proteins Against Orthomyxovirus (Influenza), Rhabdovirus, and Bunyavirus
  75. Association of TLR4 Polymorphisms with Symptomatic Respiratory Syncytial Virus Infection in High-Risk Infants and Young Children
  76. Respiratory Syncytial Virus Infects and Abortively Replicates in the Lungs in Spite of Preexisting Immunity
  77. Human metapneumovirus: Enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged
  78. The American cotton rat: A novel model for pulmonary tuberculosis
  79. Age‐Related Differences in Pulmonary Cytokine Response to Respiratory Syncytial Virus Infection: Modulation by Anti‐inflammatory and Antiviral Treatment
  80. Interferon-Inducible Mx Gene Expression in Cotton Rats: Cloning, Characterization, and Expression During Influenza Viral Infection
  81. Analysis of TLR4 Polymorphic Variants: New Insights into TLR4/MD-2/CD14 Stoichiometry, Structure, and Signaling
  82. The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease
  83. Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection
  84. The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis
  85. Pathogenesis of Human Metapneumovirus Lung Infection in BALB/c Mice and Cotton Rats
  86. Respiratory Syncytial Virus (RSV) Infection Induces Cyclooxygenase 2: A Potential Target for RSV Therapy
  87. The Cotton Rat: An Underutilized Animal Model for Human Infectious Diseases Can Now Be Exploited Using Specific Reagents to Cytokines, Chemokines, and Interferons
  88. Distinct Mutations inIRAK-4Confer Hyporesponsiveness to Lipopolysaccharide and Interleukin-1 in a Patient with Recurrent Bacterial Infections
  89. A Cotton Rat Model of Human Parainfluenza 3 Laryngotracheitis: Virus Growth, Pathology, and Therapy
  90. The role of the interferon regulatory factors, IRF-1 and IRF-2, in LPS-induced cyclooxygenase-2 (COX-2) expression in vivo and in vitro
  91. Cytokine and Chemokine Gene Expression after Primary and Secondary Respiratory Syncytial Virus Infection in Cotton Rats
  92. Emerging genetic diversity of HIV-1 in South America
  93. Interferon Regulatory Factor (Irf)-1 and Irf-2 Regulate Interferon γ–Dependent Cyclooxygenase 2 Expression
  94. Limited Role of Ceramide in Lipopolysaccharide-mediated Mitogen-activated Protein Kinase Activation, Transcription Factor Induction, and Cytokine Release
  95. The histone acetylase PCAF is a nuclear receptor coactivator
  96. Retinoid Receptor-Induced Alteration of the Chromatin Assembled on a Ligand-Responsive Promoter inXenopusOocytes
  97. Interaction between the Retinoid X Receptor and Transcription Factor IIB Is Ligand-dependentin Vivo
  98. Mutations in the 1,25-Dihydroxyvitamin D3Receptor Identifying C-terminal Amino Acids Required for Transcriptional Activation That Are Functionally Dissociated from Hormone Binding, Heterodimeric DNA Binding, and Interaction with Basal Transcription Fac...
  99. Myeloid differentiation is impaired in transgenic mice with targeted expression of a dominant negative form of retinoid X receptor β
  100. Interferon regulatory factors and TFIIB cooperatively regulate interferon-responsive promoter activity in vivo and in vitro.
  101. Inhibition of ligand induced promoter occupancyin vivoby a dominant negative RXR
  102. Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription.
  103. Retinoic acid induction of major histocompatibility complex class I genes in NTera-2 embryonal carcinoma cells involves induction of NF-kappa B (p50-p65) and retinoic acid receptor beta-retinoid X receptor beta heterodimers.
  104. Repetitive DNA sequences of Toxoplasma gondii for development of diagnostic probes
  105. Toxoplasma gondii: a rapid method for the isolation of pure tachyzoites: preliminary characterization of its genome